Table A1: Opioids

  High-risk opioid use estimate Entrants into treatment during the year Clients in substitution treatment
Opioids clients as % of treatment entrants % opioids clients injecting (main route of administration)
All entrants First-time entrants Previously treated entrants All entrants First-time entrants Previously treated entrants
Country Year of estimate cases per 1 000 % (count) % (count) % (count) % (count) % (count) % (count) count
Belgium 27.7 (3 234) 10.3 (411) 37.4 (2 773) 14 (409) 8.3 (31) 14.9 (374) 16 681
Bulgaria 84.8 (1 530) 64.5 (207) 96 (932) 73 (772) 69.9 (116) 75.5 (580) 3 423
Czech Republic 2015 1.8–1.9 17 (1 720) 7 (333) 25.9 (1 387) 82.6 (1 412) 79.8 (264) 83.2 (1 148) 4 000
Denmark 3 (613) 5.5 (124) 20.6 (472) 26.6 (121) 10.5 (11) 31.4 (108) 6 268
Germany 2014 2.7–3.3 32.9 (28 669) 13.3 (3 552) 41.4 (25 117) 32.6 (11 392) 29.4 (1 549) 33.2 (9 843) 77 200
Estonia 93.3 (263) 87.3 (55) 95 (153) 70.7 (183) 67.3 (37) 82.2 (125) 1 166
Ireland 47.6 (4 515) 25.9 (971) 62.4 (3 403) 38.2 (1 672) 30.9 (293) 39.9 (1 318) 9 917
Greece 2015 2.1–2.8 69.8 (2 836) 52.9 (834) 80.8 (1 984) 32.4 (914) 26.6 (221) 34.9 (690) 10 082
Spain 2014 1.6–2.6 24.6 (12 032) 10.5 (2 486) 42.9 (8 056) 13.7 (1 568) 7.4 (178) 15.2 (1 173) 61 859
France 2013–14 4.4–7.4 28 (13 744) 15 (2 378) 48.9 (8 310) 18.5 (2 150) 12.3 (263) 21.1 (1 505) 168 840
Croatia 2015 2.5–4.0 81.3 (6 124) 20.8 (176) 89.1 (5 917) 72.1 (4 377) 36.5 (62) 73.2 (4 299) 5 061
Italy 2015 4.6–5.9 53.3 (25 144) 38.8 (8 040) 64.6 (17 104) 50.8 (10 620) 39.5 (2 521) 55.8 (8 099) 60 047
Cyprus 2015 1.9–3.2 25.7 (205) 11.5 (50) 44.2 (142) 48 (97) 46 (23) 48.9 (68) 252
Latvia 2014 3.4–7.5 53.5 (402) 32.7 (128) 76.1 (274) 92.3 (370) 82.8 (106) 96.7 (264) 609
Lithuania 2007 2.3–2.4 89 (2 268) 66.1 (261) 94 (1 991) 87.2 (1 970) 89.3 (233) 87 (1 724) 596
Luxembourg 2007 5–7.6 56.2 (163) 25 (6) 57.9 (125) 43 (68) 16.7 (1) 42.7 (53) 1 078
Hungary 2010–11 0.4–0.5 3.6 (156) 1.6 (46) 8.4 (93) 53.5 (77) 48.9 (22) 56 (51) 669
Malta 2015 5.6–6.5 73.2 (1 296) 28.7 (66) 79.8 (1 230) 61.9 (760) 43.9 (25) 62.8 (735) 1 026
Netherlands 2012 1.1–1.5 11.5 (1 262) 6.2 (402) 19.3 (860) 6.1 (39) 7.6 (13) 5.6 (26) 7 421
Austria 2015 5.3–5.6 55.4 (2 016) 26.9 (351) 71.4 (1 665) 32.3 (516) 23 (73) 34.5 (443) 17 599
Poland 2014 0.4–0.7 16.3 (1 465) 4.8 (208) 27.6 (1 224) 62.1 (902) 40.8 (84) 65.6 (800) 2 564
Portugal 2012 4.2–5.5 49.2 (1 357) 28.9 (458) 76.8 (899) 16.6 (209) 9.9 (40) 19.8 (169) 17 011
Romania 32.6 (1 057) 17.3 (360) 66.3 (686) 88.2 (834) 85.6 (286) 90 (543) 547
Slovenia 2015 3.4–4.1 74.7 (236) 42 (37) 87.7 (199) 44.5 (105) 24.3 (9) 48.2 (96) 3 261
Slovakia 2008 1.0–2.5 24.1 (602) 14.8 (179) 33.6 (414) 68.5 (402) 51.4 (91) 75.7 (305) 600
Finland 2012 3.8–4.5 51.7 (339) 38.3 (106) 61.5 (233) 73.3 (247) 65.7 (69) 76.7 (178) 3 000
Sweden 1 25.2 (8 907) 16.8 (2 101) 29.5 (6 562) 3 679
United Kingdom 2010–11 7.9–8.4 49.7 (59 763) 21.7 (8 595) 63.5 (50 984) 31.8 (13 125) 17.5 (929) 34 (12 139) 142 085
Turkey 2011 0.2–0.5 74.2 (8 073) 67.5 (3 627) 80.7 (4 446) 24.7 (1 994) 15.5 (561) 32.2 (1 433) 12 500
Norway 2 2013 2.0–4.2 17 (1 005) 7 498
European Union 37.6 (181 918) 18.3 (32 921) 51.4 (143 189) 36.6 (55 311) 28.2 (7 550) 39 (46 856) 626 541
EU, Turkey and Norway 38.2 (190 996) 19.8 (36 548) 52 (147 635) 36 (57 305) 26.7 (8 111) 38.8 (48 289) 646 539
NB

Data on clients in substitution treatment are for 2015, or most recent year available: Denmark, Finland, Netherlands and Spain, 2014; Turkey, 2011.

  1. First-time and previously treated entrants available only for two of the three data sources available in Sweden and, therefore, not comparable with data for all entrants.
  2. The percentage of clients in treatment for opioid-related problems is a minimum value, not accounting for opioid clients registered as polydrug users.
Top